Terns Pharmaceuticals Stock Quote TERN - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

5.44

Bid

5.25

Ask

5.40

Volume

564,419

5.21 Day's Range 5.57

3.26 52 Week Range 13.51

Market Cap

351.705M

Previous Close

5.29

Open

5.39

Last Trade

5.25

Last Trade Time

Financial Volume

$ 3,023,681

VWAP

5.3572

Average Volume (3m)

957,898

Shares Outstanding

64,651,693

Dividend Yield

PE Ratio

-3.90

Earnings Per Share (EPS)

-1.4

Revenue

Net Profit

-90.21M

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ternspharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TERN. The last closing price for Terns Pharmaceuticals was $5.29. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of $ 3.26 to $ 13.51.

Terns Pharmaceuticals currently has 64,651,693 shares outstanding. The market capitalization of Terns Pharmaceuticals is $351.71 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.90.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation

Ability to dose TERN-701 without regard to food represents a key potential differentiator within the allosteric BCR-ABL inhibitor class Pharmacokinetic data show no clinically significant...

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

FOSTER CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio...

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Interim data from initial dose escalation cohorts from Phase 1 trial of TERN-701 (allosteric BCR-ABL) for treatment of CML expected in second half of 2024 Top-line data from Phase 1 trial of...

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

FOSTER CITY, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.76	16.2393162393	4.68	5.57	4.62	740094	5.07826688	CS
4	-0.04	-0.729927007299	5.48	5.79	4.32	717267	5.00502619	CS
12	-0.91	-14.3307086614	6.35	8.68	4.32	957898	6.60219755	CS
26	0.65	13.5699373695	4.79	8.68	3.26	739914	6.22572995	CS
52	-6.68	-55.1155115512	12.12	13.51	3.26	721199	7.15400438	CS
156	-16.39	-75.0801649107	21.83	21.88	1.45	365869	7.16962912	CS
260	-11.51	-67.9056047198	16.95	28.36	1.45	353315	7.75818897	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.17M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	659.97k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.41M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.17M